Volunteer s Death Unrelated To Covaxin: Bharat Biotech We cannot confirm if the volunteer received the study vaccine or a placebo as the study is blinded, the vaccine major noted. PTI outlookindia.com 2021-01-09T20:56:07+05:30
After the death of a 42-year-old volunteer in Bhopal, who took a dose of Covaxin in the clinical trial of Bharat Biotech s Covaxin, further spurred controversy over the emergency approval of the firm s covid vaccine, Bharat Biotech denied that the vaccine was the cause of the volunteer s death.
Vaccine maker Bharat Biotech on Saturday said the death of a volunteer in Bhopal, who took a shot of its COVID-19 vaccine Covaxin as part of the Phase III clinical trials, was not related to the medication.
Volunteer s death in Bhopal not related to vaccine, may be of poisoning: Bharat Biotech
India
Published: Saturday, January 9, 2021, 20:43 [IST]
New Delhi, Jan 09: Vaccine maker Bharat Biotech on Saturday said the death of a volunteer in Bhopal, who took a shot of its COVID-19 vaccine Covaxin as part of the Phase III clinical trials, was not related to the medication.
Representational Image As per the post-mortem report issued by the Gandhi Medical College, Bhopal that the site received from the Bhopal Police, the probable cause of death was due to cardio respiratory failure as a result of suspected poisoning and the case is under police investigation as well, the Hyderabad-based firm said in a statement.